Transitioning Open Heart Surgery Patients From Insulin Infusions to Detemir

Completed · Phase 4

Conditions studied: Diabetes Mellitus

In brief

In this study we will determine the proper method for transitioning patients from a continuous insulin infusion to periodic injections of a newer long-acting insulin called detemir (Levemir).

Key facts

Study ID

NCT00717288

Run by

Ohio State University

People needed

82

Starts

2008-07-01

Expected to finish

2010-06-01

Last updated by the study team

2011-10-03

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• diabetes mellitus
• post-cardiothoracic surgery
• requiring an insulin infusion of at least 1 unit/hour
• Age 18-75

You may not qualify if…

• Glucocorticoids
• total parenteral nutrition (TPN) or tube feeds
• Pregnancy
• Surgical procedures in the next 48 hours for whom intravenous (IV) insulin will be expected
• Expected length of stay less than 48 hours following cessation of the insulin drip
• Patients using subcutaneous insulin pumps
• Diabetic ketoacidosis
• End-stage renal disease
• End-stage liver disease
• Coma
• Potentially sensitive admissions: prisoners, human immunodeficiency virus(HIV), suicidality
• Unable to give consent in English

Where it is running

• The Ohio State University — Columbus, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.